Travere Therapeutics, Inc. (TVTX)

31.83 +1.39 (+4.57%) USD  |  NASDAQ  |  Apr 06, 16:00
31.86 +0.03 (+0.09%) After-Hours: 20:00
More

Travere Therapeutics Research and Development Expense (TTM) : 206.01M for Dec. 31, 2025

Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for TVTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Revolution Medicines, Inc. 978.68M
ICU Medical, Inc. 87.50M
Tandem Diabetes Care, Inc. 192.28M
iRhythm Holdings, Inc. 84.61M
Eli Lilly & Co. 13.34B